Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceu Recall: AscorbiX (Buffered C) Injection
Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceu Recall: AscorbiX (Buffered C) Injection is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical; Product: AscorbiX (Buffered C) Injection, Ascorbix (50ML) 500MG/ML Injectable, For IV, IM,
| Recalling firm | Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical |
|---|---|
| Product | AscorbiX (Buffered C) Injection, Ascorbix (50ML) 500MG/ML Injectable, For IV, IM, SC Use, Refrigerate, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0226-5 |
| Reason for recall | Lack of Assurance of Sterility |
| Classification | Class II (moderate — may cause temporary or reversible health consequences) |
| Status | Terminated |
| Distribution | U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic |
| Recall initiated | 20200115 |
| Recall number | D-0940-2020 |
| Category | drug |
| State | CA |
| Country | United States |
$29/mo
Try RecallGuard →